Trial in progress: A multicenter phase Ib/II study of pelcitoclax (APG-1252) in combination with paclitaxel in patients with relapsed/refractory small-cell lung cancer (R/R SCLC).Angel Qin, Yifan Zhai, Jyoti D. Patel et al.|Journal of Clinical Oncology|2021Cited by 5